اثربخشی هزینه دالوگلوتید در مقایسه با لیگرگلوتید و گلگرین در بیماران دیابتی نوع 2 در کلمبیا

This estimation indicates that dulaglutide dominates liraglutide. Its ICER is, however, greater than the accepted threshold for Colombia in base case compared with glargine. By increasing population weight or glargine consumption, dulaglutide becomes cost effective compared with glargine, which could identify a niche where dulaglutide is the best option.